Sign inGet started

Murphy Polly A.

Insider CIK 1829248 · AVIR Director · CELC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2026-06-182026-06-2329,600— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2026-06-182026-06-2337,700— $037,700SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2026-06-182026-06-2326,700— $026,700SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2026-06-182026-06-2329,600— $0121,745SEC↗
CELC Celcuity Inc. G Gift deriv2026-06-102026-06-1214,048— $00SEC↗
CELC Celcuity Inc. G Gift deriv2026-06-102026-06-1214,048— $014,048SEC↗
CELC Celcuity Inc. A Award2026-06-052026-06-091,530— $06,530SEC↗
AVIR Atea Pharmaceuticals, Inc. P Buy2026-05-182026-05-216,100$4.17 $25.4K92,145SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2025-06-202025-06-2429,600— $029,600SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2025-06-202025-06-2429,600— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2025-06-202025-06-2441,200— $041,200SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2025-06-202025-06-2429,600— $086,045SEC↗
CELC Celcuity Inc. G Gift deriv2025-05-282025-05-298,153— $08,153SEC↗
CELC Celcuity Inc. G Gift deriv2025-05-282025-05-298,153— $00SEC↗
CELC Celcuity Inc. A Award deriv2025-05-192025-05-2114,048— $014,048SEC↗
AVIR Atea Pharmaceuticals, Inc. P Buy2025-05-182026-05-206,100$4.17 $25.4K92,145SEC↗
CELC Celcuity Inc. G Gift deriv2024-06-242025-05-2911,645— $011,645SEC↗
CELC Celcuity Inc. G Gift deriv2024-06-242025-05-2916,300— $016,300SEC↗
CELC Celcuity Inc. G Gift deriv2024-06-242025-05-2916,300— $00SEC↗
CELC Celcuity Inc. G Gift deriv2024-06-242025-05-2911,645— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2024-06-212024-06-2141,200— $041,200SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2024-06-212024-06-2129,600— $029,600SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2024-06-162024-06-1833,150— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2024-06-162024-06-1833,150— $056,445SEC↗
CELC Celcuity Inc. A Award deriv2024-06-042024-06-068,153— $08,153SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2023-06-162023-06-2133,150— $033,150SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2023-06-162023-06-2146,750— $046,750SEC↗
CELC Celcuity Inc. A Award deriv2023-05-152023-05-1711,645— $011,645SEC↗
CELC Celcuity Inc. P Buy2022-11-222022-11-235,000$9.68 $48.4K5,000SEC↗
CELC Celcuity Inc. A Award deriv2022-09-122022-09-1416,300— $016,300SEC↗
CELC Celcuity Inc. A Award deriv2022-09-122022-09-1410,000— $010,000SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2022-06-172022-06-2161,264— $061,264SEC↗
AVIR Atea Pharmaceuticals, Inc. P Buy2021-12-202021-12-2112,000$8.57 $102.8K23,295SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2021-06-182021-06-2134,025— $034,025SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion deriv2020-11-032020-11-037,122— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion deriv2020-11-032020-11-034,173— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion2020-11-032020-11-0311,295— $011,295SEC↗